50 results

slider-website-April-2020-VODI-HF
Access

Posted on 29.04.2020

Maximising the potential of diagnostic information in heart failure care

Covid-19 has proven a seismic event for our societies, and it is easy to forget that the pandemic will not dominate the debate on healthcare forever. Yet by any rational measure, efforts to manage long-term conditions will continue to be responsible for the majority of healthcare costs into the future. Heart failure (HF) is, and […]

By Ed Harding Network Director, Heart Failure Policy Network - Co-founder and Managing Director of The Health Policy Partnership

shutterstock_1512270797
Cardio

Posted on 17.12.2019

The 3 ways in which the EU can improve peoples’ heart health

Even in 2019, cardiovascular diseases (CVD) remain the number 1 killer globally, accounting for almost 2 million deaths in the EU alone every year. These diseases are linked to huge inequalities, with more cardiovascular-related deaths in women than men, and more CVD-related deaths in middle-income than high-income countries, as a recent study from the European […]

By Jean-Luc Lemercier Corporate Vice President Edwards Lifesciences, EMEA, Canada, Latin America and JAPAC & Chair of the Cardiovascular Sector Group of MedTech Europe

shutterstock_124539028
Value

Posted on 05.12.2019

Millions of patients suffering with AF may be missing out on a life-saving procedure

Our recently published report examining the available treatment options for Atrial Fibrillation (AF) across Europe has found that millions of patients suffering with the condition don’t have access to a potentially life-saving treatment — catheter ablation therapy. Currently, 11 million people in Europe are affected by AF, a condition characterized by an irregular and often […]

By Alenka Brzulja Vice President of Cardiovascular & Specialty Solutions EMEA, Johnson & Johnson Medical Devices Companies

shutterstock_1018079914
Cardio

Posted on 25.09.2019

Treating heart valve diseases needs collaboration

World Heart Day is approaching and it deserves to be highlighted that as patient advocates in the heart valve disease sector, our relationship with the medtech industry is as important as our partnership with the medical profession and the healthcare system. We base this relationship upon the ethos of innovation, information and independence. I see […]

By Wil Woan CEO of Heart Valve Voice

Fotolia_201695872_Subscription_Monthly_M
Cardio

Posted on 19.02.2019

Atrial fibrillation: The most understated disease of our time?

In 2019, and in every corner of the world, pressing issues affect patients and their way of life. Consequently, this impacts upon their loved ones and personal, professional and social communities. There are conditions and diseases that receive a lot of attention and are broadly recognised and there are those that don’t. Atrial fibrillation (AF,) […]

By Gabriele Fischetto Vice President Cardiovascular & Specialty Solutions, Johnson & Johnson Medical Devices EMEA

heart innovation health
Cardio

Posted on 01.02.2019

Putting Health and Innovation at the heart of a European Social Contract

Given that the number of Europeans aged over 65 will double in the next 50 years, and the number of over 80 year olds will almost triple, it follows that keeping this age group in good health is a particular priority.  However, European healthcare systems are at a tipping point, driven by the increasing burden […]

By Jean-Luc Lemercier Corporate Vice President Edwards Lifesciences, EMEA, Canada, Latin America and JAPAC & Chair of the Cardiovascular Sector Group of MedTech Europe

Fotolia_191802605_Subscription_Monthly_M
Cardio

Posted on 11.10.2018

Embracing innovation and the power of positive ageing

In September, I chaired a European Parliament roundtable with MEPs and five other cardiac patient organisations on Heart Valve Disease and the Power of Positive Ageing. Our message was simple – heart valve disease is a barrier to active and healthy ageing: early detection, diagnosis and treatment with innovative medical technologies enables positive ageing. Equal […]

By Neil Johnson Chief Executive of Croí, the West of Ireland Cardiac & Stroke Foundation and the National Institute for Preventive Cardiology

New industry code must safeguard independent medical education
Ethics

Posted on 25.06.2018

New industry code must safeguard independent medical education

This blog is part of the GMTCC 2018 blog series. You can follow the conversation under #GMTCC and find more details and at gmtcc.com. Check out related blogs: Swifter, Higher, Stronger: Promoting MedTech Ethics on the Global Stage, How to create and maintain an ethical culture,Global Responsibility, Global Ethics and Compliance, Global Principles for MedTech Innovation, Progress […]

By Dr. Maarten Simoons Professor of Cardiology at European Society of Cardiology

BeFirst-banner-NEW
Chronic conditions

Posted on 07.06.2018

Kidney Disease: catch it early to save lives and money

This blog is part of the Early Diagnosis campaign #BeFirst Early diagnosis and care can prevent illness from developing and slow disease progression. Lab tests, genetic tests, tests for chronic diseases and modern lab diagnostics can help facilitate earlier intervention and improves outcomes for patients and are increasingly valuable in informing treatment choice.  Read the other […]

By Jeffrey Mayfield PhD - Sr. Scientist at Siemens Healthineers